|
Volume 271,
Number 15,
Issue of April 12, 1996 pp. 8731-8737
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Deglycosylated
Products of Endogenous Digoxin-like Immunoreactive Factor in Mammalian
Tissue
(Received for publication, July 3, 1995; and in revised form, January 3,
1996)
Hassan M. A. M.
Qazzaz
,
Steve L.
Goudy
,
Roland
Valdes
Jr.
Digoxin-like immunoreactive factor (DLIF) from adrenal cortex is
an endogenous molecule with structural features remarkably similar to
those of digoxin, a plant-derived cardiac glycoside (Shaikh, I. M.,
Lau, B. W. C., Siegfried, B. A., and Valdes, R., Jr.(1991) J. Biol.
Chem. 266, 13672-13678). Two characteristic structural and
functional features of digoxin are a lactone ring and three digitoxose
sugars attached to a steroid nucleus. Digoxin is known to undergo
deglycosylation during metabolism in humans. We now demonstrate the
existence of several naturally occurring deglycosylated components of
DLIF in human serum. The components are identified as DLIF-genin,
DLIF-mono, and DLIF-bis, corresponding to the aglycone, and the
aglycone with one and two sugars, respectively. Similar components are
produced by acid-induced deglycosylation of DLIF isolated from bovine
adrenal cortex. The elution pattern and sequence of
DLIF-deglycosylation was identical to that of digoxin suggesting
identical sugar stoichiometry. However, analysis of these newly
discovered congeners by reverse-phase chromatography,
spectrophotometry, antibody reactivity, and kinetics of
deglycosylation, demonstrates that subtle structural and physical
differences do exist when compared to digoxin. DLIF was
chromatographically distinct from digoxin, and interestingly, the
mobility of the DLIF-genin was shifted toward increased polarity
relative to digoxigenin. DLIF and DLIF-bis, -mono, and -genin congeners
have absorbance maxima at 216 nm, whereas digoxin and its congeners
absorb at 220 nm. Reaction with specific antibodies directed at the
lactone portion of these molecules shows DLIF and its deglycosylated
congeners to be 10 -fold less reactive than digoxin.
Kinetics of sugar removal suggests that DLIF is 8-fold more susceptible
to deglycosylation than is digoxin. Two less polar DLIF components
produced from the DLIF-genin have  at 196 nm and are
4-fold less immunoreactive than DLIF. Our data suggest that subtle
structural differences exist between DLIF and digoxin at or near the
lactone ring as well as in the nature of the sugars. The presence of
deglycosylated congeners of DLIF in human serum, including the less
polar components, suggests in vivo deglycosylation of these
factors. This is the first demonstration of the existence of naturally
occurring deglycosylated derivatives of DLIF and establishes the
likelihood of active metabolism of DLIF in mammals.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Y. Bagrov, J. I. Shapiro, and O. V. Fedorova
Endogenous Cardiotonic Steroids: Physiology, Pharmacology, and Novel Therapeutic Targets
Pharmacol. Rev.,
March 1, 2009;
61(1):
9 - 38.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Schoner and G. Scheiner-Bobis
Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth
Am J Physiol Cell Physiol,
August 1, 2007;
293(2):
C509 - C536.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. M.A.M. Qazzaz, Z. Cao, D. D. Bolanowski, B. J. Clark, and R. Valdes Jr
De Novo Biosynthesis and Radiolabeling of Mammalian Digitalis-Like Factors
Clin. Chem.,
March 1, 2004;
50(3):
612 - 620.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Comerford, T. J. Wallace, J. Karhausen, N. A. Louis, M. C. Montalto, and S. P. Colgan
Hypoxia-inducible Factor-1-dependent Regulation of the Multidrug Resistance (MDR1) Gene
Cancer Res.,
June 1, 2002;
62(12):
3387 - 3394.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. M. A. M. Qazzaz, M. A. El-Masri, and R. Valdes Jr.
Secretion of a Lactone-Hydrogenated Ouabain-Like Effector of Sodium, Potassium-Adenosine Triphosphatase Activity by Adrenal Cells
Endocrinology,
September 1, 2000;
141(9):
3200 - 3209.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. I. Dmitrieva, A. Y. Bagrov, E. Lalli, P. Sassone-Corsi, D. M. Stocco, and P. A. Doris
Mammalian Bufadienolide Is Synthesized From Cholesterol in the Adrenal Cortex by a Pathway That Is Independent of Cholesterol Side-Chain Cleavage
Hypertension,
September 1, 2000;
36(3):
442 - 448.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Noe, B. Hagenbuch, B. Stieger, and P. J. Meier
Isolation of a multispecific organic anion and cardiac glycoside transporter from rat brain
PNAS,
September 16, 1997;
94(19):
10346 - 10350.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|